Comparison of prognostic gene expression signatures for breast cancer

BMC Genomics

Volumn 9, Issue , 2008, Pages

  Haibe Kains, Benjamin ^a,b   Desmedt, Christine ^a   Piette, Fanny ^c   Buyse, Marc ^c   Cardoso, Fatima ^a   van't Veer, Laura ^a,d   Piccart, Martine ^a   Bontempi, Gianluca ^b   Sotiriou, Christos ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c INTERNATIONAL DRUG DEVELOPMENT INSTITUTE   (Belgium)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DISTANT METASTASIS; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC SIMILARITY; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; ALGORITHM; BREAST TUMOR; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENETICS; GENOMICS; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICS; SURVIVAL;

ADULT; ALGORITHMS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 51349107911     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-9-394     Document Type: Article

References (31)

1. Goldhirsch A Wood WC Gelber RD Coates AS Thurlimann B Senn HJ Meeting highlights: Updated international expert consensus on the primary therapy of early breast cancer J Clin Oncol 2003, 21(17):3357-3365. 10.1200/JCO.2003.04.576 12847142
2. Eifel P Axelson JA Costa J Crowley J Curran WJ Jr. Deshler A Fulton S Hendricks CB Kemeny M Kornblith AB Louis TA Markman M Mayer R Roter D National Institutes of Health Consensus Development Conference Statement: Adjuvant therapy for breast cancer, November 1-3, 2000 J Natl Cancer Inst 2001, 93(13):979-989. 10.1093/jnci/93.13.979 11438563
3. Olivotto IA Bajdik CD Ravdin PM Speers CH Coldman AJ Norris BD Davis GJ Chia SK Gelmon KA Population-based validation of the prognostic model ADJUVANT! for early breast cancer J Clin Oncol 2005, 23(12):2716-2725. 10.1200/JCO.2005.06.178 15837986
4. Sotiriou C Wirapati P Loi S Harris A Fox S Smeds J Nordgren H Farmer P Praz V Haibe-Kains B Desmedt C Larsimont D Cardoso F Peterse H Nuyten D Buyse M Van de Vijver MJ Bergh J Piccart M Delorenzi M Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis J Natl Cancer Inst 2006, 98(4):262-272. 16478745
5. van't Veer LJ Dai H van de Vijver MJ He YD Hart AA Mao M Peterse HL van der Kooy K Marton MJ Witteveen AT Schreiber GJ Kerkhoven RM Roberts C Linsley PS Bernards R Friend SH Gene expression profiling predicts clinical outcome of breast cancer Nature 2002, 415(6871):530-536. 10.1038/415530a 11823860
6. Wang Y Klijn JG Zhang Y Sieuwerts AM Look MP Yang F Talantov D Timmermans M Meijer-van Gelder ME Yu J Jatkoe T Berns EM Atkins D Foekens JA Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 2005, 365(9460):671-679. 15721472
7. Buyse M Loi S van't Veer L Viale G Delorenzi M Glas AM d'Assignies MS Bergh J Lidereau R Ellis P Harris A Bogaerts J Therasse P Floore A Amakrane M Piette F Rutgers E Sotiriou C Cardoso F Piccart MJ Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer J Natl Cancer Inst 2006, 98(17):1183-1192. 16954471
8. Desmedt C Piette F Loi S Wang Y Lallemand F Haibe-Kains B Viale G Delorenzi M Zhang Y d'Assignies MS Bergh J Lidereau R Ellis P Harris AL Klijn JG Foekens JA Cardoso F Piccart MJ Buyse M Sotiriou C Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series Clin Cancer Res 2007, 13(11):3207-3214. 10.1158/ 1078-0432.CCR-06-2765 17545524
9. Mook S Van't Veer LJ Rutgers EJ Piccart-Gebhart MJ Cardoso F Individualization of therapy using Mammaprint: From development to the MINDACT Trial Cancer Genomics Proteomics 2007, 4(3):147-155. 17878518
10. Sotiriou C Piccart MJ Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat Rev Cancer 2007, 7(7):545-553. 10.1038/nrc2173 17585334
11. van Belle G Fisher L Biostatistics: A methodology for the health sciences Wiley-Interscience Hoboken NJ 2 2004.
12. Heagerty PJ Lumley T Pepe MS Time-dependent ROC curves for censored survival data and a diagnostic marker Biometrics 2000, 56(2):337-344. 10.1111/j.0006-341X.2000.00337.x 10877287
13. Harrel FE Tutorial in biostatistics: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Statistics in Medicine 1996, 15:361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 8668867
14. Pencina MJ d'Agostino RB Overall C as a measure of discrimination in survival analysis: Model specic population value and condence interval estimation Statistics in Medicine 2004, 23:2109-2123. 10.1002/sim.1802 15211606
15. R Development Core Team A language and environment for statistical computing, R Foundation for Statistical Computing 2007.
16. Shi L Reid LH Jones WD Shippy R Warrington JA Baker SC Collins PJ de Longueville F Kawasaki ES Lee KY Luo Y Sun YA Willey JC Setterquist RA Fischer GM Tong W Dragan YP Dix DJ Frueh FW Goodsaid FM Herman D Jensen RV Johnson CD Lobenhofer EK Puri RK Schrf U Thierry-Mieg J Wang C Wilson M Wolber PK Zhang L Amur S Bao W Barbacioru CC Lucas AB Bertholet V Boysen C Bromley B Brown D Brunner A Canales R Cao XM Cebula TA Chen JJ Cheng J Chu TM Chudin E Corson J Corton JC Croner LJ Davies C Davison TS Delenstarr G Deng X Dorris D Eklund AC Fan XH Fang H Fulmer-Smentek S Fuscoe JC Gallagher K Ge W Guo L Guo X Hager J Haje PK Han J Han T Harbottle HC Harris SC Hatchwell E Hauser CA Hester S Hong H Hurban P Jackson SA Ji H Knight CR Kuo WP LeClerc JE Levy S Li QZ Liu C Liu Y Lombardi MJ Ma Y Magnuson SR Maqsodi B McDaniel T Mei N Myklebost O Ning B Novoradovskaya N Orr MS Osborn TW Papallo A Patterson TA Perkins RG Peters EH Peterson R Philips KL Pine PS Pusztai L Qian F Ren H Rosen M Rosenzweig BA Samaha RR Schena M Schroth GP Shchegrova S Smith DD Staedtler F Su Z Sun H Szallasi Z Tezak Z Thierry-Mieg D Thompson KL Tikhonova I Turpaz Y Vallanat B Van C Walker SJ Wang SJ Wang Y Wolfinger R Wong A Wu J Xiao C Xie Q Xu J Yang W Zhang L Zhong S Zong Y Slikker W Jr. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements Nat Biotechnol 2006, 24(9):1151-1161. 10.1038/nbt1239 16964229
17. Glas AM Floore A Delahaye LJ Witteveen AT Pover RC Bakx N Lahti-Domenici JS Bruinsma TJ Warmoes MO Bernards R Wessels LF Van't Veer LJ Converting a breast cancer microarray signature into a high-throughput diagnostic test BMC Genomics 2006, 7:278. 1636049 17074082 10.1186/1471-2164-7-278
18. van de Vijver MJ He YD van't Veer LJ Dai H Hart AA Voskuil DW Schreiber GJ Peterse JL Roberts C Marton MJ Parrish M Atsma D Witteveen A Glas A Delahaye L van der Velde T Bartelink H Rodenhuis S Rutgers ET Friend SH Bernards R A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 2002, 347(25):1999-2009. 10.1056/NEJMoa021967 12490681
19. Foekens JA Atkins D Zhang Y Sweep FC Harbeck N Paradiso A Cufer T Sieuwerts AM Talantov D Span PN Tjan-Heijnen VC Zito AF Specht K Hoefler H Golouh R Schittulli F Schmitt M Beex LV Klijn JG Wang Y Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer J Clin Oncol 2006, 24(11):1665-1671. 10.1200/JCO.2005.03.9115 16505412
20. Chang HY Sneddon JB Alizadeh AA Sood R West RB Montgomery K Chi JT van de Rijn M Botstein D Brown PO Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds PLoS Biol 2004, 2(2):E7. 314300 14737219 10.1371/ journal.pbio.0020007
21. Paik S Shak S Tang G Kim C Baker J Cronin M Baehner FL Walker MG Watson D Park T Hiller W Fisher ER Wickerham DL Bryant J Wolmark N A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 2004, 351(27):2817-2826. 10.1056/NEJMoa041588 15591335
22. Perou CM Sorlie T Eisen MB van de Rijn M Jeffrey SS Rees CA Pollack JR Ross DT Johnsen H Akslen LA Fluge O Pergamenschikov A Williams C Zhu SX Lonning PE Borresen-Dale AL Brown PO Botstein D Molecular portraits of human breast tumours Nature 2000, 406(6797):747-752. 10.1038/35021093 10963602
23. Sorlie T Perou CM Tibshirani R Aas T Geisler S Johnsen H Hastie T Eisen MB van de Rijn M Jeffrey SS Thorsen T Quist H Matese JC Brown PO Botstein D Eystein Lonning P Borresen-Dale AL Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 2001, 98(19):10869-10874. 58566 11553815 10.1073/pnas.191367098
24. Sorlie T Tibshirani R Parker J Hastie T Marron JS Nobel A Deng S Johnsen H Pesich R Geisler S Demeter J Perou CM Lonning PE Brown PO Borresen-Dale AL Botstein D Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci U S A 2003, 100(14):8418-8423. 166244 12829800 10.1073/pnas.0932692100
25. Fan C Oh DS Wessels L Weigelt B Nuyten DS Nobel AB van't Veer LJ Perou CM Concordance among gene-expression-based predictors for breast cancer N Engl J Med 2006, 355(6):560-569. 10.1056/NEJMoa052933 16899776
26. Thomassen M Tan Q Eiriksdottir F Bak M Cold S Kruse TA Comparison of gene sets for expression profiling: Prediction of metastasis from low-malignant breast cancer Clin Cancer Res 2007, 13(18 Pt 1):5355-5360. 10.1158/1078-0432.CCR-07-0249 17875763
27. Klein CA Blankenstein TJ Schmidt-Kittler O Petronio M Polzer B Stoecklein NH Riethmuller G Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer Lancet 2002, 360(9334):683-689. 10.1016/S0140-6736(02)09838-0 12241875
28. Schmidt-Kittler O Ragg T Daskalakis A Granzow M Ahr A Blankenstein TJ Kaufmann M Diebold J Arnholdt H Muller P Bischoff J Harich D Schlimok G Riethmuller G Eils R Klein CA From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression Proc Natl Acad Sci U S A 2003, 100(13):7737-7742. 164657 12808139 10.1073/ pnas.1331931100
29. Yu JX Sieuwerts AM Zhang Y Martens JW Smid M Klijn JG Wang Y Foekens JA Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer BMC Cancer 2007, 7:182. 2077336 17894856 10.1186/1471-2407-7-182
30. Desmedt C Haibe-Kains B Wirapati P Buyse M Larsimont D Bontempi G Delorenzi M Piccart MJ Sotiriou C Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes Clin Cancer Res 2008, 14:16. 18698033
31. Rouzier R Perou CM Symmans WF Ibrahim N Cristofanilli M Anderson K Hess KR Stec J Ayers M Wagner P Morandi P Fan C Rabiul I Ross JS Hortobagyi GN Pusztai L Breast cancer molecular subtypes respond differently to preoperative chemotherapy Clin Cancer Res 2005, 11(16):5678-5685. 10.1158/1078-0432.CCR-04-2421 16115903